Anzeige
Meldung des Tages: Verdoppelt – und noch nicht am Ziel? Dieser Rohstoff-Explorer profitiert vom Antimon-Boom

Northwest Biotherapeutics News

Aktie
WKN:  A1J5EY ISIN:  US66737P6007 US-Symbol:  NWBO Branche:  Biotechnologie Land:  USA
0,2289 $
+0,0054 $
+2,42%
0,19695 € 09.03.26
Depot/Watchlist
Marktkapitalisierung *
305,51 Mio. €
Streubesitz
-
KGV
-
Index-Zuordnung
-

Northwest Biotherapeutics News

20.11.25 - PR Newswire
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility PR Newswire
20.11.25 - PR Newswire
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility
Northwest Biotherapeutics Announces That Construction Activities Are Under Way For the First Grade C Manufacturing Suite in the Sawston, UK Facility PR Newswire
24.10.25 - PR Newswire
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed PR Newswire
24.10.25 - PR Newswire
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed PR Newswire
27.08.25 - PR Newswire
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. PR Newswire
27.08.25 - PR Newswire
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd.
Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. PR Newswire
18.08.25 - PR Newswire
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman PR Newswire
18.08.25 - PR Newswire
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman
Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman PR Newswire
11.06.25 - PR Newswire
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-​Tumor Treatments PR Newswire
11.06.25 - PR Newswire
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments
Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-​Tumor Treatments PR Newswire

Newssuche

Videos

newspaper
04.03.26 -6,24%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »